NewsAvi Kapoor
Bicara Therapeutics
BCAX · NASDAQ
$18.35+$0.88 (+5.04%)TodayMarket closed ·
Prev close $17.47
Latest news
- Press releaseGlobe Newswire
Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth
- Press releaseGlobe Newswire
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
- Press releaseGlobe Newswire
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
- Press releaseGlobe Newswire
Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
- News
Earnings Scheduled For May 11, 2026
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- News
Earnings Scheduled For March 30, 2026
- Press releaseGlobe Newswire
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
- Press releaseGlobe Newswire
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
- Press releaseGlobe Newswire
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
- Press releaseGlobe Newswire
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
- Press releaseGlobe Newswire
Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook
- Press releaseGlobe Newswire
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
- Press releasePRNewswire
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
- Press releasePRNewswire
Rice Biotech Launch Pad welcomes Carolyn Ng to external advisory board
- Press releaseBusiness Wire
Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies
- NewsAvi Kapoor
Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook
- NewsAvi Kapoor
Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results
- NewsAvi Kapoor
Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- News
Market-Moving News for May 23rd
- NewsAvi Kapoor
This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- Press releaseGlobe Newswire
Bicara Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsAvi Kapoor
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- NewsAvi Kapoor
This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- NewsAvi Kapoor
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.